Thyrotoxic periodic paralysis in pregnancy with impaired glucose tolerance: A case report and discussion of management issues

Thyroid

Volumn 17, Issue 6, 2007, Pages 579-583

  Donovan, Lois ^a,b   Parkins, Vicky M ^a   Mahalingham, Aishling ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Alberta Health Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LABETALOL; MAGNESIUM; POTASSIUM; PROPYLTHIOURACIL; PROSTAGLANDIN; THYROTROPIN;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; DRUG DOSE INCREASE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOKALEMIA; IMPAIRED GLUCOSE TOLERANCE; MAGNESIUM BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PREGNANCY; PRIORITY JOURNAL; QUADRIPLEGIA; THYROID FUNCTION; THYROTOXIC PERIODIC PARALYSIS; THYROTROPIN BLOOD LEVEL;

ADULT; FEMALE; GLUCOSE TOLERANCE TEST; GRAVES DISEASE; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; THYROTOXICOSIS;

EID: 34447550343     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0288     Document Type: Article

References (37)

1. Mellgren G, Bleskestad IH, Aanderud S, Bindoff L 2002 Thyrotoxicosis and paraparesis in a young woman: case report and review of the literature. Thyroid 12:77-80.
2. Shizume K, Shishiba Y, Kuma K, Noguchi S, Tajiri J, Ito K, Noh JY 1992 Comparison of the incidence of association of periodic paralysis and hyperthyroidism in Japan in 1957 and 1991. Endocrinol Jpn 39:315-318.
3. Kung AW 2006 Clinical review. Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 91:2490-2495.
4. Khan FA, Baron DN 1987 Ion flux and Na+,K+-ATPase activity of erythrocytes and leucocytes in thyroid disease. Clin Sci (Lond) 72:171-179.
5. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R 1991 In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis. BMJ 303:1096-1099.
6. Lam KS, Yeung RT, Benson EA, Wang C 1989 Erythrocyte sodium-potassium pump in thyrotoxic periodic paralysis. Aust N Z J Med 19:6-10.
7. Curfman GD, Crowley TJ, Smith TW 1977 Thyroid-induced alterations in myocardial sodium-potassium-activated adenosine triphosphatase, monovalent cation active transport, and cardiac glycoside binding. J Clin Invest 59:586-590.
8. Riis AL, Jorgensen JO, Moller N, Weeke J, Clausen T 2005 Hyperthyroidism and cation pumps in human skeletal muscle. Am J Physiol Endocrinol Metab 288:E1265-1269.
9. Ismail-Beigi F 1993 Thyroid hormone regulation of Na, K-ATPase expression. Trends Endocrinol Metab 4:152-155.
10. Ewart HS, Klip A 1995 Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 269:C295-311.
11. Lee KO, Taylor EA, Oh VM, Cheah JS, Aw SE 1991 Hyperinsulinaemia in thyrotoxic hypokalemic periodic paralysis. Lancet 337:1063-1064.
12. Hundal HS, Marette A, Mitsumoto Y, Ramlal T, Blostein R, Klip A 1992 Insulin induces translocation of the alpha 2 and beta 1 subunits of the Na+/K(+)-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 267:5040-5043.
13. Layzer RB 1982 Periodic paralysis and the sodium-potassium pump. Ann Neurol 11:547-552.
14. Peleg D, Cada S, Peleg A, Ben-Ami M 2002 The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 99:1040-1043.
15. Polak M, Le Gac I, Vuillard E, Guibourdenche J, Leger J, Toubert ME, Madec AM, Oury JF, Czernichow P, Luton D 2004 Fetal and neonatal thyroid function in relation to maternal Graves' disease. Best Pract Res Clin Endocrinol Metab 18:289-302.
16. Wallace C, Couch R, Ginsberg J 1995 Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment. Thyroid 5:125-128.
17. Dias Da Silva MR, Cerutti JM, Arnaldi LA, Maciel RM 2002 A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab 87:4881-4884.
18. Schalin-Jantti C, Laine T, Valli-Jaakola K, Lonnqvist T, Kontula K, Valimaki MJ 2005 Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis. Horm Res 63:139-144.
19. Kung AW, Lau KS, Fong GC, Chan V 2004 Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 89:1340-1345.
20. Lane AH, Markarian K, Braziunene 12004 Thyrotoxic periodic paralysis associated with a mutation in the sodium channel gene SCN4A. J Pediatr Endocrinol Metab 17:1679-1682.
21. Kung AW, Lau KS, Cheung WM, Chan V 2006 Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium ATPase genes. Clin Endocrinol (Oxf) 64:158-161.
22. Damallie KK, Drake JG, Block WA 2000 Hypokalemic periodic paralysis in pregnancy after 1-hour glucose screen. Obstet Gynecol 95:1037.
23. Bowman ML, Bergmann M, Smith JF 1998 Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. Thyroid 8:795-796.
24. Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K 1986 Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 315:24-28.
25. Iheonunekwu NC, Ibrahim TM, Davies D, Pickering K 2004 Thyrotoxic hypokalaemic paralysis in a pregnant Afro-Caribbean woman. A case report and review of the literature. West Indian Med J 53:47-49.
26. Richey SD, Wendel GD Jr 1993 Thyrotoxic hypokalemic periodic paralysis following second-trimester prostaglandin-induced abortion. Obstet Gynecol 82:696-698.
27. Al-Shoumer KA, Vasanthy BA, Al-Zaid MM 2006 Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Endocr Pract 12:121-130.
28. Bech K, Damsbo P, Eldrup E, Beck-Nielsen H, Roder ME, Hartling SG, Volund A, Madsbad S 1996 beta-cell function and glucose and lipid oxidation in Graves' disease. Clin Endocrinol (Oxf) 44:59-66.
29. Mouradian M, Abourizk N 1983 Diabetes mellitus and thyroid disease. Diabetes Care 6:512-520.
30. Chaudhury S, Ismail-Beigi F, Gick GG, Levenson R, Edelman IS 1987 Effect of thyroid hormone on the abundance of Na, K-adenosine triphosphatase alpha-subunit messenger ribonucleic acid. Mol Endocrinol 1:83-89.
31. Viscomi CM, Ptacek LJ, Dudley D 1999 Anesthetic management of familial hypokalemic periodic paralysis during parturition. Anesth Analg 88:1081-1082.
32. Robinson JE, Morin VI, Douglas MJ, Wilson RD 2000 Familial hypokalemic periodic paralysis and Wolff-Parkinson-White syndrome in pregnancy. Can J Anaesth 47:160-164.
33. Fukuda K, Ogawa S, Yokozuka H, Handa S, Nakamura Y 1988 Long-standing bidirectional tachycardia in a patient with hypokalemic periodic paralysis. J Electrocardiol 21: 71-75.
34. Wong GW, Leung TF, Lo AF, Ahuja AT, Cheng PS 2000 Thyrotoxic periodic paralysis in a 14-year-old boy. Eur J Pediatr 159:934.
35. Li Y, Isomaa V, Pulkka A, Herva R, Peltoketo H, Vihko P 2005 Expression of 3beta-hydroxysteroid dehydrogenase type 1, P450 aromatase, and 17beta-hydroxysteroid dehydrogenase types 1,2,5 and 7 mRNAs in human early and mid-gestation placentas. Placenta 26:387-392.
36. Biering H, Bauditz J, Pirlich M, Lochs H, Gerl H 2003 Manifestation of thyrotoxic periodic paralysis in two patients with adrenal adenomas and hyperandrogenaemia. Horm Res 59: 301-304.
37. Sugishita K, Li F, Su Z, Barry WH 2003 Anti-oxidant effects of estrogen reduce [Ca2+]i during metabolic inhibition. J Mol Cell Cardiol 35:331-336.